SU‐E‐T‐718: Automatic IMRT Plan Quality Control for GYN Cancer Clinical Trials

T. Song, N. li, Y. Graves, Q. Gautier, M. Zarepisheh, Y. li, A. Mundt, L. Zhou, K. Moore, C. Yashar, L. Mell, X. Jia, S. Jiang, L. Cervino

Research output: Contribution to journalArticle

Abstract

Purpose: To perform efficient quality control (QC) of intensity‐modulated radiotherapy (IMRT) plans of gynecological (GYN) cancer in clinical trials. Methods: Plan QC is a necessary component in clinical trials that requires much time and effort. IMRT plans from the INTERTECC clinical trial for the treatment of intact cervix cancer patients have been used to evaluate a plan QC tool. The CT image, organ and target contours, and the clinical IMRT plan were imported into a GPU‐based treatment re‐planning system that was originally designed to perform online adaptive radiotherapy. The clinical plan was considered as the reference plan and the re‐planning system automatically created a new plan. The objective for re‐planning was to reduce dose of organs‐at‐risk (OARs) and to get a more uniform dose in the PTV with respect to the reference plan. After performing automatic re‐planning on each plan, we compared the new and the reference DVH curves in terms of the treatment planning goals specified in the clinical trial protocol. Results: Data from 12 patients was retrospectively analyzed. Results showed that DVH curves of the automatic plan satisfy the specified clinical constraints more frequently than the actual clinical plans. DVH for the PTV of the new plan was in most cases similar to the clinical plans, indicating good quality PTV coverage. In 2 out of the 12 cases the QC tool could achieve a PTV hotspots reduction of 11% and 10% respectively. For most patients, lower doses in OARs were achieved after re‐planning, except in those plans where there was overlap between OARs and PTV. Re‐planning takes less than 1 min for each case. Conclusion: We have proved the feasibility of efficient IMRT plan QC in clinical trials for patients with GYN cancer. Varian Medical Systems through a Master Research Agreement.

Original languageEnglish (US)
Pages (from-to)371
Number of pages1
JournalMedical Physics
Volume40
Issue number6
DOIs
StatePublished - 2013

Fingerprint

Quality Control
Radiotherapy
Clinical Trials
Neoplasms
Clinical Protocols
Uterine Cervical Neoplasms
Therapeutics
Research

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

Song, T., li, N., Graves, Y., Gautier, Q., Zarepisheh, M., li, Y., ... Cervino, L. (2013). SU‐E‐T‐718: Automatic IMRT Plan Quality Control for GYN Cancer Clinical Trials. Medical Physics, 40(6), 371. https://doi.org/10.1118/1.4815145

SU‐E‐T‐718 : Automatic IMRT Plan Quality Control for GYN Cancer Clinical Trials. / Song, T.; li, N.; Graves, Y.; Gautier, Q.; Zarepisheh, M.; li, Y.; Mundt, A.; Zhou, L.; Moore, K.; Yashar, C.; Mell, L.; Jia, X.; Jiang, S.; Cervino, L.

In: Medical Physics, Vol. 40, No. 6, 2013, p. 371.

Research output: Contribution to journalArticle

Song, T, li, N, Graves, Y, Gautier, Q, Zarepisheh, M, li, Y, Mundt, A, Zhou, L, Moore, K, Yashar, C, Mell, L, Jia, X, Jiang, S & Cervino, L 2013, 'SU‐E‐T‐718: Automatic IMRT Plan Quality Control for GYN Cancer Clinical Trials', Medical Physics, vol. 40, no. 6, pp. 371. https://doi.org/10.1118/1.4815145
Song, T. ; li, N. ; Graves, Y. ; Gautier, Q. ; Zarepisheh, M. ; li, Y. ; Mundt, A. ; Zhou, L. ; Moore, K. ; Yashar, C. ; Mell, L. ; Jia, X. ; Jiang, S. ; Cervino, L. / SU‐E‐T‐718 : Automatic IMRT Plan Quality Control for GYN Cancer Clinical Trials. In: Medical Physics. 2013 ; Vol. 40, No. 6. pp. 371.
@article{f42190bbadc344bfb0c0cad93b2d0342,
title = "SU‐E‐T‐718: Automatic IMRT Plan Quality Control for GYN Cancer Clinical Trials",
abstract = "Purpose: To perform efficient quality control (QC) of intensity‐modulated radiotherapy (IMRT) plans of gynecological (GYN) cancer in clinical trials. Methods: Plan QC is a necessary component in clinical trials that requires much time and effort. IMRT plans from the INTERTECC clinical trial for the treatment of intact cervix cancer patients have been used to evaluate a plan QC tool. The CT image, organ and target contours, and the clinical IMRT plan were imported into a GPU‐based treatment re‐planning system that was originally designed to perform online adaptive radiotherapy. The clinical plan was considered as the reference plan and the re‐planning system automatically created a new plan. The objective for re‐planning was to reduce dose of organs‐at‐risk (OARs) and to get a more uniform dose in the PTV with respect to the reference plan. After performing automatic re‐planning on each plan, we compared the new and the reference DVH curves in terms of the treatment planning goals specified in the clinical trial protocol. Results: Data from 12 patients was retrospectively analyzed. Results showed that DVH curves of the automatic plan satisfy the specified clinical constraints more frequently than the actual clinical plans. DVH for the PTV of the new plan was in most cases similar to the clinical plans, indicating good quality PTV coverage. In 2 out of the 12 cases the QC tool could achieve a PTV hotspots reduction of 11{\%} and 10{\%} respectively. For most patients, lower doses in OARs were achieved after re‐planning, except in those plans where there was overlap between OARs and PTV. Re‐planning takes less than 1 min for each case. Conclusion: We have proved the feasibility of efficient IMRT plan QC in clinical trials for patients with GYN cancer. Varian Medical Systems through a Master Research Agreement.",
author = "T. Song and N. li and Y. Graves and Q. Gautier and M. Zarepisheh and Y. li and A. Mundt and L. Zhou and K. Moore and C. Yashar and L. Mell and X. Jia and S. Jiang and L. Cervino",
year = "2013",
doi = "10.1118/1.4815145",
language = "English (US)",
volume = "40",
pages = "371",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - SU‐E‐T‐718

T2 - Automatic IMRT Plan Quality Control for GYN Cancer Clinical Trials

AU - Song, T.

AU - li, N.

AU - Graves, Y.

AU - Gautier, Q.

AU - Zarepisheh, M.

AU - li, Y.

AU - Mundt, A.

AU - Zhou, L.

AU - Moore, K.

AU - Yashar, C.

AU - Mell, L.

AU - Jia, X.

AU - Jiang, S.

AU - Cervino, L.

PY - 2013

Y1 - 2013

N2 - Purpose: To perform efficient quality control (QC) of intensity‐modulated radiotherapy (IMRT) plans of gynecological (GYN) cancer in clinical trials. Methods: Plan QC is a necessary component in clinical trials that requires much time and effort. IMRT plans from the INTERTECC clinical trial for the treatment of intact cervix cancer patients have been used to evaluate a plan QC tool. The CT image, organ and target contours, and the clinical IMRT plan were imported into a GPU‐based treatment re‐planning system that was originally designed to perform online adaptive radiotherapy. The clinical plan was considered as the reference plan and the re‐planning system automatically created a new plan. The objective for re‐planning was to reduce dose of organs‐at‐risk (OARs) and to get a more uniform dose in the PTV with respect to the reference plan. After performing automatic re‐planning on each plan, we compared the new and the reference DVH curves in terms of the treatment planning goals specified in the clinical trial protocol. Results: Data from 12 patients was retrospectively analyzed. Results showed that DVH curves of the automatic plan satisfy the specified clinical constraints more frequently than the actual clinical plans. DVH for the PTV of the new plan was in most cases similar to the clinical plans, indicating good quality PTV coverage. In 2 out of the 12 cases the QC tool could achieve a PTV hotspots reduction of 11% and 10% respectively. For most patients, lower doses in OARs were achieved after re‐planning, except in those plans where there was overlap between OARs and PTV. Re‐planning takes less than 1 min for each case. Conclusion: We have proved the feasibility of efficient IMRT plan QC in clinical trials for patients with GYN cancer. Varian Medical Systems through a Master Research Agreement.

AB - Purpose: To perform efficient quality control (QC) of intensity‐modulated radiotherapy (IMRT) plans of gynecological (GYN) cancer in clinical trials. Methods: Plan QC is a necessary component in clinical trials that requires much time and effort. IMRT plans from the INTERTECC clinical trial for the treatment of intact cervix cancer patients have been used to evaluate a plan QC tool. The CT image, organ and target contours, and the clinical IMRT plan were imported into a GPU‐based treatment re‐planning system that was originally designed to perform online adaptive radiotherapy. The clinical plan was considered as the reference plan and the re‐planning system automatically created a new plan. The objective for re‐planning was to reduce dose of organs‐at‐risk (OARs) and to get a more uniform dose in the PTV with respect to the reference plan. After performing automatic re‐planning on each plan, we compared the new and the reference DVH curves in terms of the treatment planning goals specified in the clinical trial protocol. Results: Data from 12 patients was retrospectively analyzed. Results showed that DVH curves of the automatic plan satisfy the specified clinical constraints more frequently than the actual clinical plans. DVH for the PTV of the new plan was in most cases similar to the clinical plans, indicating good quality PTV coverage. In 2 out of the 12 cases the QC tool could achieve a PTV hotspots reduction of 11% and 10% respectively. For most patients, lower doses in OARs were achieved after re‐planning, except in those plans where there was overlap between OARs and PTV. Re‐planning takes less than 1 min for each case. Conclusion: We have proved the feasibility of efficient IMRT plan QC in clinical trials for patients with GYN cancer. Varian Medical Systems through a Master Research Agreement.

UR - http://www.scopus.com/inward/record.url?scp=85024823099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024823099&partnerID=8YFLogxK

U2 - 10.1118/1.4815145

DO - 10.1118/1.4815145

M3 - Article

AN - SCOPUS:85024823099

VL - 40

SP - 371

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -